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Carbon-based nanomaterialsThe SARS-CoV-2 virus is still causing a dramatic loss of human lives worldwide, constituting an unprecedented
challenge for the society, public health and economy, to overcome. The up-to-date diagnostic tests, PCR, anti-
body ELISA and Rapid Antigen, require special equipment, hours of analysis and special staff. For this reason,
many research groups have focused recently on the design and development of electrochemical biosensors for
the SARS-CoV-2 detection, indicating that they can play a significant role in controlling COVID disease. In this
review we thoroughly discuss the transducer electrode nanomaterials investigated in order to improve the sen-
sitivity, specificity and response time of the as-developed SARS-CoV-2 electrochemical biosensors. Particularly,
we mainly focus on the results appeard on Au-based and carbon or graphene-based electrodes, which are the
main material groups recently investigated worldwidely. Additionally, the adopted electrochemical detection
techniques are also discussed, highlighting their pros and cos. The nanomaterial-based electrochemical biosen-
sors could enable a fast, accurate and without special cost, virus detection. However, further research is
required in terms of new nanomaterials and synthesis strategies in order the SARS-CoV-2 electrochemical
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Currently, SARS-CoV-2 can be diagnosed by two different ways: i)
antigen tests (point-of-care, POC) and ii) molecular tests (nucleic acid,
RNA or PCR-polymerase chain reaction) [1–3]. Antigen tests can
detect parts of SARS-CoV-2 proteins, known as antigens, via a
nasopharyngeal or nasal swab sampling method [4]. The main advan-
tages of POC-test include the high specificity, quick response (less than
an hour) and portability, with no need of fixed laboratory facilities. On
the other hand, in a molecular diagnostic test, a reverse transcriptase
polymerase chain reaction (RT-PCR) is evolved, also known as nucleic
acid amplification method [3], which requires expensive laboratory
equipment. According to the chain reaction, virus RNA is converted
to its DNA and then is amplified, using polymerase enzymes, by pro-
ducing millions of DNA copies until they become detectable [3]. This
process is characterized of high sensitivity and specificity, while the
sample required can be taken from the saliva, or the respiratory system
or the nasal cavity (nasopharyngeal or nasal swab sampling method).
However, this method is time-consuming, and it requires several hours
for the analysis of the results [5].
Antibody or serology tests are searching for antibodies in human
blood to determine if there were a past infection with the virus that
causes COVID-19. Antibodies are proteins created by human body's
immune system, soon after the infection or vaccination. These tests
cannot be classified as diagnostic tools. However, they can be used
to struggle the COVID-19 disease. It is suggested the antibody tests
to be complementary used to the PCR ones, as their specificity for
the SARS-CoV-2 has been reported higher than 99.5% and their sensi-
tivity higher than 91%. Especially for patients exhibiting prolonged
symptoms or for those who are asymptomatic, the antibody test can
offer an extra appeasement of being cleared from the virus. However,
the challenge that must be overcome is the unknown lasting period of
immunity, as well as the degree of a body’s immunity [6]
Meanwhile, despite the great efforts of the scientific community
towards the development of diagnostic tools and the achievement of
high specificity and sensitivity of the molecular tests, the concern
about the control and detection of the SARS-CoV-2 remains until the
complete vaccination of the population will be achieved. This concern
begins from the complexity the diagnostic tools present, as well as the
time and the specialised personnel they demand, however the main
roots are localized in the SARS-CoV-2 behaviour (e.g. continuous
mutations - changes to new variants - like the S. African and the Indian
ones etc.) and its rapid spread.
Today, the results of the as developed vaccines are visible, but most
of the population has still not been vaccinated, so people must be
repeatedly screened for COVID-19 disease. Even those proven not
infected, taking negative results from molecular tests, it is possible
the same day to be infected by the virus and so the test should be
repeated, and many more tests are recommended. Moreover, accord-
ing to the U.S. food and drug administration [7], the amplification pro-
cess of the RT-PCR test should not exceed the forty cycles (one cycle
contain the heating and cooling process to make copies of a specific
region of DNA); even after so many cycles the available amount of
genetic material is very low to be detectable. Thus, the difficulty to
achieve the as called herd immunity the spread of the virus’ infection,
the continuous mutations of the virus, the complexity of the diagnostic
tools, create a vicious cycle that would be interrupted only when appro-
priate diagnostic tools and efficient therapy protocols will be
developed.
The evolution of the electrochemical biosensors over the years and
their involvement into medical diagnostic field, for diabetes [8–13],
Alzheimer [14–16] and other diseases, show that they could be a suc-
cessful virus diagnostic tool of high sensitivity, specificity, low cost,
quick response, requiring no special personnel and offering the advan-
tage of the portability.2
Recently, Ji et al. [17] reviewed the already developed detection
techniques of SARS-CoV-2, confirming our abovementioned notifica-
tion that the lack of the appropriate detection technology for patients
with low load of virus and the necessity of early detection, pointing
out the role the biosensors could play in struggling the virus. Further-
more, according the Mahshid et al. [18] survey, the electrochemical
biosensors offer the alternative of using different analytes, thus detect-
ing the virus at any stage of its evolution without worrying about its
load. Among them, the electrochemical biosensors detecting viral
nucleic acids exhibited the highest sensitivity. The limited results qual-
ity of commercially available kits (e.g. self-tests) and the need for early
SARS-CoV-2 diagnosis through a simple process, rightly point out that
electrochemical biosensors could offer a safer solution.
The advances of the electrochemical biosensors (EBs) and the
importance of viruses electrochemical sensing were recently reviewed
by Ruiz de Eguilaz et al. [19]. They reported that the research interest,
concerning the development of these biosensors, focuses mainly on the
sample preparation strategies, the point-of-care platforms and the tar-
get analyte, while the low sensitivity (compared to molecular tests) is
the main challenge that remains to be overcome.
Furthermore, as reported by Khan et al. [20], the sensitivity and the
lifetime of an electrochemical biosensor depend: i) on the method of
virus immobilization on the electrode and ii) on the electrode’s mate-
rial. Asif et al. [21] also recognized, among other biosensors, the
important role of the electrochemical ones for the detection of acute
respiratory syndromes, like SARS-CoV-2, highlighting the role
nanoscience should play for the improvement of virus antigens selec-
tivity and sensitivity. Srivastava et al. [22] discussed the significant
role and the contribution of various developed nanomaterials for res-
piratory infections sensing, emphasizing on the different biosensing
tools. They recognised that Au, lanthanide-doped polysterene
nanoparticles, graphene and iron oxide nanoparticles-based biosensors
that detect RNA or DNA and protein (antigen or antibody), are consid-
ered the main nanomaterials under investigation. In a more extensive
review by Bukkitgar et al. [23], about electrochemical biosensors for
viruses (including SARS-CoV-2) detection, suggested graphene nano-
materials as the most promising ones for such application. They specif-
ically focused on the preparation method and the surface
functionalization strategies that could help to eliminate the contami-
nation, caused by other bioreceptors bound on them.
Moreover, as Kudr et al. [24] and Kotru et al. [25] highlighted that
the electrochemical biosensors are of the most ambitious contestants
in the fight against COVID-19 disease. According to Kotru et al. the
use of the optimum biomarker can further enhance virus electrochem-
ical sensing process, providing also a picture of the disease evolution.
Considering the above works devoted to the kind of electrode, the
analysis method, the kind of biomarker and the basic principle of anal-
ysis, one might conclude that they mainly offer a good qualitative
comparison.
With the current review we aim to thoroughly summarize and dis-
cuss the materials recently investigated as electrode transducers for
the development of SARS-CoV-2 electrochemical biosensors, empha-
sizing on their quantitative characteristics, such as sensitivity, lower
limit of detection, specificity and response time. More precisely, we
seek to examine the operating parameters of the electrode materials
investigated for SARS-CoV-2 detection. In addition, this review deals
with the electrochemical techniques being used for the SARS-CoV-2
electrochemical biosensors evaluation, which as we noticed, constitute
a controversial subject in the scientific community.
1.1. Operational principles of biosensors
Generally, a typical sensor is a device used for measuring a physical
quantity (input), which is converted into a signal (output, electrical or
optical) that is then interpreted by the specialists. Accordingly, a
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antibody or other) and its role is to capture the target analyte (e.g. a
virus) and ii) a transducer, the role of which is to transform the signal
produced from the biomolecule in electricity (current or potential) or
other kind of signal depending on the type of transducer (Fig. 1Α). The
recorded signal is usually amplified by a signal processing circuit and
the interpreted results are displayed in a computer or a smartphone
[26].
Biological analytes, due to their intrinsic physical properties, are
hard to be directly detected, so an element such as a radioactive or a
fluorescent dye, nanoparticles or enzymes (known as label), can be
either immobilized onto the bioreceptor surface (antibody) or onto
the target molecule (Fig. 1B). The main drawback of the labelling pro-
cedure is that it is time-consuming, as well as laborious and cost inten-
sive. Furthermore, sometimes the labelling of biomolecules may block
active binding sites, leading to the modification of binding properties
attributed to the unknown degree of affinity between the target ana-
lyte and the bioreceptor [27], thus reducing biosensors sensitivity,
selectivity and reproducibility.
On the contrary, label-free biosensors detect the analytes, utilizing
intrinsic physical properties (electrical impedance, dielectric permit-
tivity, or refractive index, etc.) of the analytes in their natural form
(Fig. 1B). For example, when the electrical change is studied, the con-
duction or resistance or capacity is measured; in the case of mechani-
cal change the mass and frequency changes are measured; in the case
of optical elements the adsorption and emission of light are measured.
Label-free biosensing methods are rapid and of low cost, using
small reaction volumes. Moreover, they can be integrated into lab-
on-chip platforms, detecting in real time the concentration of the tar-Fig. 1. (Α) Operational principle of a biosensor; (B) Label-free and label-based d
Antibody-aptamer sandwich type (a&b), aptamers pair sandwich type (c&d). Repr
3
get analyte and reducing the adsorption of non-specific molecules
[27]. Especially the new strategy in label free detection, using apta-
mers/oligonucleotides [28], offers the opportunity of analysing vari-
ous target analytes, even those with small molecules, which
otherwise - with the common label-free sensing method - would
require more time and special attention. The aptamers, which are
in vitro synthesized, usually form non-covalent bonds with the target
analyte, increasing biosensor’s specificity and sensitivity towards a
precise target. Generally, aptamers (usually a single-stranded DNA/
RNA oligonucleotide sequence) are immobilised onto transducer solid
surface (electrode transducer) and usually bind to the virus protein
[29] (Fig. 1C). When the aptamer binds to the target-analyte acts as
a barrier that increases the sensing surface resistance, preventing the
electrons transfer to the electrode. The amount of the target sample
is proportional to the charge resistance [30].
The main advantages of the aptamers are as follows: they can be
chemically modified for increasing their stability and affinity towards
the target analyte and can be synthesized in large amounts, when their
nucleic sequence becomes known [31]. However, even though apta-
mers are considered as the next generation bioreceptors, the up-to-
date commercialized ones do not use a single aptamer, since it presents
instability as far as concerns the reproducibility and the signal gener-
ation. Thus, as an alternative, either the pair antibody-aptamer sand-
wich type [(Fig. 1D (a & b)] or the aptamers pair sandwich-type
(aptamer1-target-aptamer2), were developed [(Fig. 1D (c & d)] [32].
From the four SARS-CoV-2 structural properties (spike, envelope,
matrix and nucleocapsid), the spike protein (S1 and S2) is usually cho-
sen as the domain receptor, since it constitutes a trans-membrane pro-
tein of the virus-cell with high immunogenicity, having the ability toetection process of biosensors; (C) Label-free aptamer detection process; (D)
oduced with permission.
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Moreover, the spike protein has affinity with the angiotensin-convert-
ing enzyme 2 (hACE2), which is used as a receptor infecting human
cells [34,35]. Currently the aptamers, having affinity with the SARS-
CoV-2 spike protein, were identified through the known Systematic
Evolution of Ligands by Exponential enrichment system or “SELEX” sys-
tem [36]. According to this process, a variety of polynucleotides (ap-
tamer pool) are exposed to the target molecule and the aptamers
with higher affinity are in vitro selected and then eluted, while the rest
is disregarded (Fig. 2A).
This process is repeated many times until a small number of apta-
mers with high affinity and specificity against the desired target will
remain.
Today, one of the SARS-CoV-2 diagnostic tools is based on an
enzyme-linked immunosorbent assay (ELISA) biosensor. The opera-
tional key principle is based onto the target-analyte interaction with
the enzyme-antibody complex, followed by an enzymatic reaction,
which is responsible for the signal production. In Fig. 2(Bi and Bii)
are depicted the direct and indirect detection processes, respectively.
At the direct detection, the target-analyte is adsorbed directly on theFig. 2. (A) SELEX procedure for aptamers production; (B) Direct (i) and indirect
with permission.
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microplates’ surface (Fig. 2Bi), with the risk that undesired proteins
(albumin) will also be adsorbed. On the other hand, at the indirect
detection process, the indirect adsorption (sandwich structure: anti-
body-analyte-antibody, seen in Fig. 2Bii), exhibits higher specificity
as the adsorption is more selective. In both cases the analyte amount
is specified via the colour change from the enzyme reaction [37].
1.2. Electrochemical biosensors
An electrochemical transducer is characterized of the lower cost,
simpler construction, higher specificity, relatively lower sensitivity
and portability. Their operational principle is based on the recording
of the electrical signal, produced when the bioreceptor selectively
reacts with the target-analyte (labelled or not labelled), which is pro-
portional to the analyte’s concentration [38].
According to the identification process of the target-analyte, the
electrochemical biosensors are classified as: i) biocatalytic and ii)
affinity sensors. A biocatalytic electrochemical biosensor includes usu-
ally enzymes, the role of which is to identify the target-analyte produc-
ing electroactive species. On the other hand, the operation of an(ii) detection (enzyme-linked immunosorbent assay ELISA) [37]. Reproduced
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between a bioreceptor (antibody, enzyme, nucleic acid or other recep-
tor) and the consequent production of an electrical signal (Fig. 1A).
For the virus diagnosis, the affinity electrochemical biosensors are
chosen. Usually the binding process includes antibody-antigen interac-
tion (Fig. 3A) or DNA hybridization (Fig. 3B). Immunosensors opera-
tion is based on the interaction between the antibody, immobilized
on the sensing surface of the electrode, and the antigen of a specific
analyte. When the binding process takes place, an electrical current
is produced accordingly to the antigen concentration of target analyte,
which then it is amplified and displayed [39]. The challenges of the
immunosensors, however, led also to the development of bio recogni-
tion procedure, using DNA or RNA fragments [40]. It should be noted
that among immunosensors, the electrochemical ones have been more
perfectionized mainly because of their simplicity and, their ability to
be portable, and for their in situ or automated detection.
At the hybridization procedure, the single-stranded DNA segments,
placed onto the surface of the sensing electrode (DNA probes), bind
selectively with the complementary part of the target-analyte’s DNA
(pair-base procedure), producing an electrical current/signal. After-
wards, the confirmation of a successful hybridization process occurs:
i) using electroactive complexes (redox indicators), such as ferrocenyl
naphthalene diimide that present different affinity towards a single
stranded DNA, than to a double strand (successful hybridization)
[41] or ii) using enzymatic labels, such as horseradish peroxidase; then
from the occurring redox reactions the produced current is measured.
Lately, nanoparticles are investigated as electrochemical labels,
because compared to enzymes own higher stability and conductivity,
offering faster electron transfer from the immobilized target to the
electrode. At the DNA hybridization procedure, in absence of labels,
the guanine base is oxidized on the electrode’s surface, while the pro-
duced current can be amplified by the aid of redox mediators [e.g. Ru
(bpy)3+2] [42]. At this method, the success of the hybridization proce-
dure is checked by measuring the changes of transducer’s capacitance
or conductivity [43].
The shape as well as the size of the binding site define the degree of
affinity, sensitivity and selectivity and it is critical for each kind of
biosensor. The main challenge of immunosensors is the antibody
(Ab) production for a specific virus antigen (Ag) to a host organism,
which is a time consuming and costly process. The immobilization of
the antibody on the solid surface of the electrode is another challenge
to overcome. In case the antibodies are immobilised with wrong orien-
tation they may lose their binding ability being unable to provide a
highly sensitive biosensor. Moreover, in the case of DNA biosensors
the orientation and the amount of the DNA probe are very important,
confirming the significant role the electrode material plays. For this
reason, the DNA molecules should be immobilized in a specific orien-Fig. 3. (A) Antibody-antigen electrochemical immunosensors. (B) DNA-b
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tation to maintain stability and activity, and the other characteristics
as well [44]. Moreover, in order to avoid the binding of undesired spe-
cies, the surface of the electrode should be covered with blocking
agents.
When the aptamer production is adopted, a series of DNA or RNA
oligonucleotides (aptamers) are produced, which detect and bind
selectively to a three-dimensional surface, such as the one of proteins
(Fig. 1C). The sequences of the aptamers are produced via a poly-
merase chain reaction (PCR).
Therefore, for achieving the optimal characteristics for biosensors
operation, the choice of electrode material along with its treatment
procedure is of great importance. Notably, the immobilization proce-
dure has been improved by far due to the development of nanomate-
rials [45] and their use in electrochemical immunosensors. For this
reason, the choice and the treatment of the electrode’s material of
the up-to-date developed SARS-Co-V2 electrochemical biosensors are
thoroughly discussed in the present review.1.3. Electrochemical detection techniques
Today, most of the biosensors are fabricated using electrochemical
transducers, as they are simple to be constructed, easy to use, require
small reaction volumes and the measurement is not affected by foreign
interferences, such as red-blood cells, etc. The principle of operation of
an electrochemical transducer is based on the measurement either of
current, or charge accumulation or alteration of the electrode conduc-
tion, caused by a “reaction”. Therefore, based on the measured prop-
erty, the electrochemical detection techniques can be classified into:
i) amperometric or voltametric (current is measured), ii) impedance
biosensors (conduction or resistance is measured) and iii) potentiomet-
ric ones (potential is measured) [46,47].1.3.1. Amperometric or voltametric-based detection
By using the amperometric detection method, a constant potential
is applied at the working electrode (vs the reference electrode) and an
electrochemical oxidation or reduction takes place, delivering a cur-
rent. The as produced current (measured vs a counter electrode) is pro-
portional to the concentration of target analyte into the sample [48].
When the measurement is conducted applying the rotating disk elec-
trode technique [49], the mass transport rate of the analyte onto the
working electrode surface can be enhanced.
This method is mainly adopted for both the biocatalytic and affinity
biosensors as they own the advantage of very low detection limit and
very high selectivity towards target analyte. Moreover, the applying of
an exact potential, which causes the electrochemical oxidation or
reduction reaction, is a time-consuming detection procedure [50].ased electrochemical immunosensors. Reproduced with permission.
G. Balkourani et al. Journal of Electroanalytical Chemistry 893 (2021) 115289On the other hand, according to the voltametric detection method,
the working electrode is imposed to work under a potential range (vs a
reference electrode) into which an electrochemical oxidation or reduc-
tion reaction occurs, and the produced current is measured (vs a coun-
ter electrode). The current response is proportional to the analyte
concentration when applying the techniques of differential pulse
voltammetry, cyclic voltammetry, square-wave voltammetry and lin-
ear sweep voltammetry [50]. Nowadays, aptamer based biosensors
[51], which are considered as the next generation biosensors, tend
to adopt the voltammetric sensing techniques, exploiting the robust-
ness and the very low detection limits they present even with small
amounts of analyte volume.Table 1
Determination factors of the efficiency [38].
Efficiency of an electrochemical biosensor
Accuracy The amount of uncertainty in a measurement, compared to a1.3.2. Electrochemical impedance spectroscopy (EIS)-based detection (or
impedimetric detection)
According to the electrochemical impedance technique, a small AC
excitation signal (2–10) mV under a specific frequency (Hz) range, is
emitted to the electrode under investigation, and by measuring the
in and out-phase current response, the parameters of electrode's resis-
tance and conductivity are estimated. [52]. At high frequency values
the electron transfer can be estimated, while the mass transfer is esti-
mated at low frequency values.
EIS is primarily used for the affinity evaluation of label-free electro-
chemical immunosensors for the direct control of the antibody-antigen
binding process, taking place onto the electrode’s surface.
Indicatively, before the measurement the surface of the working
electrode is covered (using electrodeposition method) with a highly
conductive polymeric film, where the bioreceptors are incorporated
too. The detection process takes place by applying a known potential,
which causes a current flux and consequently an electron transfer. The
electron transfer resistances, at the electrode and at the bulk of analyte
interface, change as the target analyte binds onto the bioreceptor. The
resistances change, measured with EIS, is proportional to the antigen
concentration. In this way the formation of the antibody-antigen bond-
ing layer can be appropriately monitored, without the necessity of
using labels [53]. Nevertheless, the main disadvantage of this type
of detection is the low regeneration possibility of the working
electrode.
The lower cost, the quicker response of assays, and the higher sig-
nal to noise ratio, are some of the main advantages of the electrochem-
ical impedance detection. Nevertheless, the main disadvantage of this
type of detection is the low regeneration ability of the working elec-
trode [54].reference. The accuracy is important in order to evaluate the
correct quantity (usually molarity) of the target-analyte.
Response time The time interval between the moment the analyte gets into
contact with the bioreceptor and the moment the electric signal is
received. A quick response time is preferable if the sensor is used
as a device of point-of-care.
Selectivity The ability of a sensor to preferably analyze the desired analyte in
presence of other substances. The high selectivity ensures higher
lifetime and accuracy of a sensor.
Repeatability It ensures that an electrochemical sensor will give the same
output for over a period. It represents a factor along with the
reproducibility that determines a sensor’s reliability.
Reproducibility The ability of an electrochemical sensor to give the same signals
under varied measurement conditions.
Detection limit The lowest detection limit is the lowest concentration of the
target-analyte that can be tracked with accuracy.
Sensitivity The lowest difference identified by a sensor, after the change of
analyte’s concentration. A sensor with very high sensitivity can
even detect very small changes of analyte concentration.
Recovery time The minimum time between two successive measurements.
Before the second measurement starts, the sensor should return
into its initial condition.
Linear range The electric signal received from the sensor should be linearly
dependenton the analyte concentration. So, the minimum and
maximum concentration that could be analysed by a sensor, are
determined.1.3.3. Potentiometric detection
According to the potentiometric method the sensor is consisted of
two reference electrodes that are fixed onto a layer, whose potential
change is measured when it reacts selectively with the charged ion
of the target analyte. The charged ion produced by the aid of an
enzyme, which catalyzes a specific reaction, causes the potential dif-
ference the membrane presents before and after the charge ion is
produced.
The field effect transistors-based biosensors [55] belong to this cat-
egory; consisted of a biological recognition compartment and a field-
effect transistor (semi-conducting material). Between the analyte solu-
tion and the semiconductor there is an insulating (chemically and elec-
trically) layer that is usually a polymer onto which the bioreceptors are
placed. When the binding procedure (bioreceptor-target analyte)
becomes successful, the surface of the electrolyte-insulator layer elec-
trostatic potential changes is recorded, which accordingly cause an
electrostatic gating effect to the semiconductor as well as a current dif-
ference between the source and the drain electrodes that is also
recorded.6
1.4. Efficiency characteristics of electrochemical biosensors
The efficiency of an electrochemical biosensor is determined by its:
i) accuracy, ii) response time, iii) selectivity, iv) repeatability, v) repro-
ducibility, vi) detection limit, vii) sensitivity, viii) recovery time and
ix) linear range [38], characteristics that are explained in the Table 1.2. Emerging transducer electrode materials for viruses’
electrochemical detection
The development of nanotechnology has helped the growth of
biotechnology, allowing emerged new possibilities that have greatly
improved the efficiency features of biosensors [56]. The adoption of
nanomaterials for the transducer electrode structure of electrochemi-
cal biosensors enhanced their sensitivity, selectivity, response time,
making them more accessible for virus detection.
Specifically, as many researchers support, the transducer electrode,
in which an aptamer or an antibody combines with a nanomaterial
(hybrid material), transmits a higher signal, and presents increased
sensitivity and affinity towards the target analyte, especially when a
nanomaterial is used as label [57]. Among the examined nanomateri-
als, gold nanoparticles [58,59] are mostly investigated as they are bio-
compatible, with excellent electrical and optical properties. Moreover,
gold nanoparticles improve the immobilization of the bioreceptors
onto the electrode transducer, providing a larger surface area, which
allow the immobilization of higher number of bioreceptors [57].
Therefore, today the scientists pay more attention to further modify
the gold nanoparticles either by exploring different supports, such as
multiwall carbon nanotubes, graphene, etc, or adopting other prepara-
tion strategies.
In the next sub-section, we discuss indicatively some interesting
methods applied the last five years for the fabrication of nanomate-
rial-based electrochemical MERS-CoV, HCoV and SARS-CoV biosen-
sors. Our attention then is focused to the respective electrochemical
biosensors developed for the SARS-CoV-2; we analytically discuss
the use of nanomaterials for the fabrication of electrodes and their
effect onto biosensor characteristics.
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SARS-CoV viruses
The use of Au surfaces as electrodes in electrochemical biosensors
is not new. On 2005 Abad-Valle et al. [60] developed for the first time
a very thin sputtered Au-nanofilm (100 nm thickness) onto a poly-
imide substrate, as transducer-electrode in a DNA hybridization assay
for the SARS virus electrochemical detection. The thickness of the as-
prepared electrode allowed researchers to use small reaction volumes,
enabling the simultaneous hybridization and sequential detection
offering more than twenty assay sites. During the detection, the com-
plementary strand of a specific SARS-DNA sequence was labeled with
thiol group and immobilized on the Au surface.
The electrochemical detection is amplified with alkaline phos-
phatase-labelled streptavidin; while for the expulsion of the undesired
molecules from electrode surface, albumin and 1-hexanethiol are
tested as blocking agent, as depicted in Fig. 4A. Moreover, the opera-
tional parameters of the biosensor were evaluated, using the following
electrochemical methods: i) cyclic voltammetry, ii) differential pulse
voltammetry, iii) alternating current and iv) square wave voltamme-
try. It is remarkable that the lowest detection limit of the biosensor
was found to be 6 pM (pM = 10−12 M) [60].Fig. 4. (A) Comparison of LSV measurements in 1 μM DNA solution for albumin (a)
of SARS genome (oligonucleotides sequence) bound on the modified electrode, pro
contained in the solution, are reduced into metallic silver (Ag) [62]. CVs of methyle
molecule (Dii) on bare (dotted line) and nanostructured screen-printed electrodes
dsDNA/rAzu (black), and PSD/rAzu (red). In presence of Ag + ions and oligonu
Reproduced with permission.
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Later, in 2007, De la Escosura-Muñiz et al. [61], developed a DNA
hybridization electrochemical genosensor for SARS detection that
exhibited a lower limit of detection at 15 fM (fM = 10−15 M). The
deposition of electroactive Au label complexes onto the modified (with
DNA-probe) glassy carbon electrode allowed the electrochemical
detection through the Ag electro-reduction reaction, which was cat-
alyzed by the electrodeposited Au complex. As shown in Fig. 4B, the
greater is the degree of DNA binding, the greater the amount of the
electrodeposited Au on the glassy carbon and thus the greater the Ag
reduction current recorded will be. Over the years, it is observed that
the Au in combination with the electroactive species instead of
enzymes play an important role for the electrochemical genosensors
evolvement. However, despite the lower limit of detection that was
achieved, there are also several processes that should be further opti-
mized. One of them is the labeling process, which is time consuming,
and the process of the binding verification between the metal and the
oligonucleotide that should be done through the label (e.g. thiol
group).
Moreover, in 2009 Martinez-Paredes et al. [62] suggested DNA
hybridization over Au nanoparticles supported onto carbon screen-
printed transducer electrodes for SARS virus electrochemical genosen-
sors fabrication. Thus, for the first time Au nanoparticles wereand 1-hexanethiol (b) blocking agents on electrode surface [60]. (B) The DNA
ducing current [61]. (Ci) Ag reduction current recorded by CV. (Cii) Ag ions,
ne blue covalently attached to a single-stranded DNA (Di) and methylene blue
(solid line) [65]. (Ε) Comparison of CV response between the dsDNA (blue),
cleotides molecules (C = 0.5 pM (10−12 M), rAzu: 0.1 × 10−3g/mL) [66].
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in combination with the use of screen-printed electrodes, led to
reduced interaction time between Au and thiol (label), high sensitivity
(1.76 mA/pM) and relatively low detection limit (2.5 pM). At the same
time, the Au-nanoparticles managed to retain their electrocatalytic
activity, to immobilize the analyte molecules and to amplify the
DNA detection ability. This threefold function led to less analysis time
and improved stability of the biosensor.
The evaluation of the as-fabricated biosensor is achieved by using
cyclic voltammetry (Fig. 4Ci), estimating the produced current from
the electrochemical oxidation of the deposited metallic Ag, which
acted as electroactive species. As seen in Fig. 4Cii, before the detection
procedure, the silver ions contained in the solution are reduced to
metallic silver (Ag) and deposited next to the enzymatic label AP (al-
kaline phosphatase), using a reducing agent produced by the 3-indoxyl
phosphate substrate. The amount of the deposited Ag was measured,
using anodic stripping voltammetry.
Thus, for many scientists the question about the effect of the
amount of Ag and other electroactive species arises, as well as of the
amount of the immobilized elements, on the efficiency of the biosen-
sor. The answer was provided by Layqah and Eissa [63], who also
investigated the maximum concentration of antibodies that could be
accepted on Au-nanoparticles and the binding-time required. It should
be mentioned that the immunosensor performance is affected by both
parameters, in terms of limits of detection and response time.
Initially when the science of nanotechnology was introduced into
the biosensors field, managed to make the analysis simpler, quicker,
with higher sensitivity, including many other desirable characteristics.
However, point-of-care diagnosis, with a real sample, without the need
of an electrochemical cell, was a real challenge that should be over-
come. So, the robustness for on-site analysis was emerged with the
appearance of screen-printed carbon electrodes (SPCEs) combined
with nanotechnology. SPCEs was and still remains a leading technol-
ogy, mainly due to the attractive characteristics offered by carbon
material, such as low cost, chemical inertness, low background cur-
rents and good conductivity under specific conditions [64].
One of the first carbon material investigated from the scientific
community were screen-printed carbon electrodes for the DNA
hybridization, during the DNA electrochemical detection. In the case
of an ideal immobilization, the probes are oriented towards the immo-
bilized layers, being ready to facilitate the detection procedure.
So, since hybridization process is based on the immobilization of a
single stranded DNA (ssDNA) and on the complementary binding of
the DNA sequence on the sensing carbon electrode, owning a surface
area that can be easily modified, (for example with metal nanoparti-
cles [61], or polymers or other nanomaterials) and thus consisting a
very attractive option all over the years. In addition, the subsequent
appearance of carbon nanotubes (CNT) and their chemical, mechanical
and unique electrical properties, have motivated the scientific commu-
nity to explore their application in the field of electrochemical biosen-
sors, modifying with them the SPCEs surface.
García-González [65] reported for the first time the fabrication of
an electrochemical DNA biosensor based on carbon nanotubes (CNTs)
modified Au-SPCEs (commercial) and methylene blue labelled DNA,
aiming at the SARS-CoV detection. The use of the CNTs enables the
methylene blue utilization as an electrochemical label that is cova-
lently attached to a single-stranded DNA, thus facilitating the higher
electron transfer, as seen in Fig. 4Di, compared to methylene blue
molecule without DNA-attachment (Fig. 4Dii).
More specifically, the chemistry of the CNTs surface allows the
adsorption of such molecules, which in their turn amplify the analyti-
cal signal. Following this strategy, it has been managed a seven times
higher sensitivity, fact that led to use differential pulse voltammetry
and square wave voltammetry, which are very sensitive electrochemi-
cal detection techniques and usually applied for the measurement of
very low current values. However, comparable to Au transducer elec-8
trodes, the sensitivity (0.2864 μA μM−1) was not very high, and the
limit of detection remained at the nanoscale (800 nM), indicating that
further research is necessary.
Recently, for the simultaneous detection of various CoV viruses,
[63]. Au nanoparticles electrodeposited on carbon disposable-microar-
ray transducer electrodes (eight in number), were used for the first
time. The electrodeposition procedure was performed using cyclic
voltammetry at a specific negative potential range. After the Au-elec-
trodeposition, human corona virus (HCoV) or MERS-CoV antigens (re-
combinant spike protein S1) were immobilized on Au via a simple and
time-consuming incubation procedure. According to the optimal oper-
ating conditions of the immunosensor for the successful detection,
approximately 20 min of analyte sample incubation was required to
take place and a specific concentration of antibodies (~10 μg L−1)
should be included in the sample.
However, the main novelty of the as-proposed biosensor [61]
derives from the way in which the advantages of the combination
between nanotechnology and electrochemical science were exploited.
Specifically, by using four electrodes for MERS-CoV detection and two
electrodes for HCoV detection, duplicate measurements for each sam-
ple were achieved.
The square wave voltammetry technique and ferro/ferricyanide
redox-couple system (electroactive substance) were employed [63]
in order to evaluate both the antigen binding onto the working elec-
trodes (after being modified with serum albumin, BSA - bovine serum
albumin - that prevents undesired molecules to bound onto the elec-
trode) and the investigation of the novel immunosensors operational
parameters. When the peak reduction current (derived from the redox
reactions) is decreased, the antibody is successfully bound to the
immobilized antigen (spike protein S1), blocking the access of the
ferro/ferricyanide redox couple to the working electrode. Thus, even
after many years of research the Au nanoparticles-based electrochem-
ical biosensors, which are considered better devices as compared to
the other types of biosensors, present some limitations, such as the
lower limit of detection that depends on the amount of the antigen
(consequently the virus antibody) immobilized on the nanomaterials
[57], and few others.
Understanding these limitations, few research groups [66–69]
adopted metalloproteins making labels or other linkers unnecessary.
Namely, Mohammadniaei et al. [66] immobilized the recombinant
azurin protein (r-Azu) on a Au-electrode. The protein had a cross-sec-
tional diameter (the smallest circle through which a molecule can
pass) and thus, the as-fabricated electrode acted as an arrayed mole-
cule with selectivity towards the analyte molecule, receiving only
one DNA strand [at its N-terminus: the free amine group (–NH2)
located at the end of a polypeptide or protein], for the development
of electrochemical biosensors for the detection of MERS-CoV and other
viruses.
The researchers in order to reduce the possibility of foreign mole-
cules to be anchored onto the Au-electrode, fabricated a series of
azurin- single stranded DNA-parallel two double stranded DNA (like
a chain), which was repeated all over the Au-surface. This unique strat-
egy of the adoption of two double stranded DNA in a parallel arrange-
ment gave the opportunity for a higher specificity detection of small
nucleic acids, such as miRNA or virus DNA. Moreover, at the plasma
pH (7.4), the azurin caused a negative charge of the electrode surface,
which was responsible for the vertical arrangement of the DNA strands
onto the electrode. This vertical position of the DNA strand helped to
eliminate the lateral adsorptions of it [66].
The as-suggested electrode was evaluated by measuring the electri-
cal conductivity change, using Ag ion (Ag+) reduction, which played
the role of the charge carrier in the case of mismatch between pairs
or virus detection. For the Ag+ reduction reaction the cyclic voltam-
metry technique was chosen. By scanning at negative potential values
(reduction), the charge is transferred from the Au electrode to azurin
(copper protein), then to DNA that acts as a charge mediator and
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mation of distinct peak current curves clearly defines that the Ag+ can
sufficiently play the role of the redox element that accepts electrons in
free-label DNA electrochemical biosensors. Despite the main advan-
tage of the as-suggested biosensor, the optimum detection time was
one hour, indicating that further research should be done to reduce
the response time.
The above-mentioned limitations, such as the concentration of anti-
bodies, the need for higher sensitivity, the binding of undesired species
and the low reproducibility of an electrochemical biosensor, require a
more mannered treatment (or functionalization) of the surface of nano
catalyst or the exploitation of other nanomaterials than gold nanopar-
ticles to be further investigated.
2.2. Electrochemical biosensors for the detection of SARS-CoV-2
Facing the need of developing tools for rapid SARS-CoV-2 detec-
tion, many research groups responded immediately by fabricating
and studying a few novel electrochemical platforms based mostly on
Au and carbon or graphene nanomaterials. In the current section the
most relevant works published in international literature are discussed
in terms of the used electrode transducer materials and electrochemi-
cal detection techniques. The response time, the lower limit of detec-
tion and the electrochemical techniques of biosensor evaluation
characteristics are reported and discussed in terms of electrode mate-
rials choice.
2.2.1. Au-based SARS-CoV-2 electrochemical biosensors
Table 2 lists the Au-based SARS-CoV-2 electrochemical biosensors,
their response time, the used electrochemical techniques for each
biosensor evaluation characteristics and their limit of detection. As
above-mentioned, antibodies-sensors can play a significant role mainly
in identifying the prevalence of a disease, which in turn could help the
doctors to decide the best treatment and the scientists to understand
the kinetics (evolution) of a virus over time and so providing them
more information for developing the appropriate vaccines.
Au-based electrodes placed on a commercial sensing polyethylene
terephthalate (PET) substrate platform (Fig. 5Ai) were adopted by
Rashed et al. [70] in order to develop a capacitive immunosensor for
SARS-CoV-2 antibodies detection. Gold (Au) is a safe choice, as among
the electrochemical biosensors it is the most investigated material,
being explored in combination with various substrate platformsTable 2
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(screen printed electrodes, polymer base platforms, etc). However,
the properties of the substrate material affect the efficiency of sensors,
while many concerns have been expressed about the reproducibility of
the deposition of the sensing layer onto the substrate surface [76].
The PET platform produced by Rashed et al. [70] was label-free and
able to immobilize COVID-19 antibodies onto the Au electrodes coated
with the RBD (receptor binding domain) SARS-CoV-2 spike protein.
The detection tests were implemented using electrochemical impe-
dance spectroscopy (EIS), by measuring the changes of electrode’s con-
ductivity. More precisely, the interface between the Au surface and the
RBD SARS-CoV-2 spike protein along with the bound antibodies form
an electrical double layer, as depicted in Fig. 5Ai, whose resistance
increases when in the analysis sample anti-SARS-CoV-2 monoclonal
antibodies are present. According to the reported results [70], it was
observed that the thickness of the electrical double layer, its shape
and therefore the measured conductivity, depend on the binding
events (probe-target binding) and the time-range they occur. The bind-
ing events depend on the concentration of virus’ antibodies in the anal-
ysis sample, as well as on the probe's concentration on the electrode
surface; both parameters affect the frequency under which the EIS
measurement is performed. For example, they analyzed three samples
in a specific frequency. Two of them (samples A and B) contained dif-
ferent concentrations of the analysis target (SARS-CoV-2 antibodies),
while the third one (sample C) contained no analysis target. As seen
in Fig. 5Aii, when the binding event occurs, a conduction peak is
instantly recorded (in the initial 5–10 s), while in ~ 30 s the conductiv-
ity is rapidly reduced. This change of the electrical behavior is attrib-
uted to the association and dissociation event of the antibody/target
(binding event) that alters the whole conductivity. However, one
might wonder to what extent the EIS technique could be sufficiently
employed, at the same operational parameters (frequency and mV),
under higher or lower concentrations of the under-detection target.
It can be concluded that as the process evolves, i.e. as the experimental
conditions change (when the antibodies of the sample are reduced),
the EIS detection sensitivity is reduced leading to false conclusions.
Thus, the optimum parameters of this electrochemical biosensor type
should be defined each time.
Similarly, Bajo et al. [71] exploiting the special properties of Si sub-
strate, developed an Au-based SARS-CoV-2 sensor in one chip having
three operating modes: i) an electrical heater, ii) a temperature sensor
and iii) an electrochemical sensor for detecting the virus targeted
nucleic acids (NAs) (Fig. 5Bi). The NAs detection was achieved havinge Immobilized element Response
time
Limit of detection
monoclonal antibody CR3022/SARS-CoV-2 spike <5 min –
cDNA/SARS-CoV-2 antigen – Artificial
target:0.02 pg
cDNA/complementary thiolated probes – –
spike S1 protein/SARS-CoV-2 Spike S1 antibody 3 min Artificial target:1
pg/L
spike S1 protein and RDB antibodies/SARS-CoV-2
BD antigens
11.5sec Artificial targets:
1) 1 pM for spike
S1 protein





RNA (without amplification)/SARS-CoV-2 capture
bel probe (LP), and auxiliary probe (AP)
<10 sec Artificial target:




Fig. 5. (Ai) A schematic illustration of a label-free platform, able to immobilize COVID-19 antibodies on the Au electrodes, coated with RBD SARS-CoV-2 spike-
protein; (Aii) Change of the electrical double layer resistance between the Au surface and the RBD bound on it, when antibodies are detected (samples A,B are
infected with the virus, while sample C is not) [70]; (Bi) Au-based SARS-CoV-2 sensor in one chip with three operating modes; (Bii) Comparison of
electroanalytical signals between SARS-CoV-2 (2003) cDNA and SARS-CoV2-cDNA [71]; (C) Electrodeposited Au nanoparticles, where thiol is immobilized/self-
assembled and operated as probe for bound the RNA/c-RNA of SARS-CoV-2 [72]; (Di, Dii) Change in electric properties of a cell-membrane, when the S1 protein
(antigen) of SARS-CoV-2 is bound with the immobilized antibody on the Au electrode surface (screen-printed electrode) [73]. Reproduced with permission.
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could be analyzed either under a specific temperature or under a cyclic
operation between different temperatures (with a precision of ±1.3 °
C). Non-covalent methylene blue (MB+) constitutes a commonly used10intercalative redox indicator that is interposed into the DNA base stack
[77]. As discussed in section two, the intercalators (or redox-active
reporters) are substances that form intermolecular (non-covalent)
bonds with DNA, and they are used in the time-consuming chemical
G. Balkourani et al. Journal of Electroanalytical Chemistry 893 (2021) 115289cross-linking steps [77] as they are able to be reduced and oxidized,
producing electric current when the target of interest bounds to the
electrode’s probe [78].
Moreover, Bajo et al. [71], amplified the DNA (repeated copying of
a piece of DNA) and measured in real-time the concentration of ampli-
cons (one or more copies of a genetic fragment of DNA), using square
wave voltammetry (SWV), performing an indirect measurement of the
produced current. When new amplicons are produced during amplifi-
cation, the methylene blue (MB) is interacting with them, without
interacting with the working electrode, therefore the measured current
is originated from the redox reactions between MB and amplicons. In
order to evaluate the produced electroanalytical signal, for comparison
reasons, fragments from another coronavirus (SARS-CoV (2003)
cDNA) were used. As shown in Fig. 5 Bii, after 35 PCR cycles the elec-
troanalytical signals for the two viruses differ by about four times,
indicating the ability of the sensor to separate the two viruses. For
the designed sensor, a LOD of 20 fg (fg = 10−15g) (or 0.02 pg
(pg = 10−12 g)) was calculated, in a solution containing 50–150 nM
of SARS-CoV-2 cDNA (synthetic).
Square wave voltammetry (SWV) is such a sensitive pulse-voltam-
metry technique the analysis results of which can be compared with
those of spectroscopic and chromatographic techniques. Based on its
operational principle, the produced current varies according to both
the potential step and the duration of potential application [79]. More-
over, similarly to the cyclic voltammetry technique, when the sweep
rate increases the recorded current increases too, with the difference
that the peak potential increases accordingly instead of remaining con-
stant, making the SWV more popular among sensitive medical diag-
nostic analysis.
Furthermore, compared to the other electrochemical detection
techniques, SWV requires higher frequency values, thus reducing the
analysis time. However, similarly to the EIS technique, the SWV mea-
surement should be optimized in terms of applied frequency, voltage
step, amplitude and target analyte concentration. Therefore, in the
future the modification of SWV operational parameters under various
target analysis concentrations should be examined.
Following the safe choice offered by Au nanoparticles, Tripathy et
al. [72] electrodeposited them onto a Ti substrate and suggested the
development of an electrochemical label-free COVID-19 transducer.
In the last years, it was observed the adoption of titanium substrate
as surface support for metallic nanoparticles, and its application as
transducer electrode for electrochemical biosensors, due to its reason-
able cost, improved mechanical stability and its good conductivity
[80].
As depicted in Fig. 5C, after the Au electrodeposition thiol (probe),
as a self-assembled element, is immobilized onto the Au nanoparticles.
The rest of the surface is covered with a blocking agent in order to
block the binding of undesired molecules on the sensing electrode.
When the target DNA binds to the probe, the hybridization procedure
modifies the charge of the sensing surface. The produced current,
which according to the authors can be measured with the amperome-
try technique, is proportional to the concentration of the bound-target,
for a specific probe density bound on the electrode [72]. However,
further research about the response time, lower limit of detection
and other efficiency characteristics should be explored for the above
sensor.
A novel approach based on the combination of the membrane engi-
neering field with the electrochemical analysis field, was proposed by
Mavrikou et al. [73] in order to electrochemically detect SARS-CoV-2
S1 protein. They electrodeposited SARS-CoV-2 Spike S1 antibody into
kidney cells, as depicted in Fig. 5Di, which then are immobilized onto
Au-screen printed carbon electrodes (commercial). As shown in Fig.
5Dii, when the S1 protein (antigen) of SARS-CoV-2 bound onto the
immobilized antibody, the potential of the cell-membrane is altered
and appropriately measured. For a quick reading of the results, the
novel biosensor can also be connected to a smartphone or a tablet.11More precisely, the authors [73] achieved a lower detection limit of
1 fg/mL (fg/mL = 10−15 g/mL) and a good selectivity for SARS-
CoV-2 antigen, when other virus-associated proteins were also present.
Specifically, a semi-linear behavior was observed in the range between
10 fg/mL and 1 μg/mL. However, at concentrations higher than 10 fg/
mL the sensor response is decreased. This means that maybe more cells
is necessary to be bound onto the Au surface in order to facilitate more
targets or independently target-molecules competing each other for
the binding sites. The main advantage of this biosensor [73] was the
ability to detect the virus antigen within 3 min, without need any prior
sample processing. However, the main limitation of the as-suggested
electrochemical detection method is the necessity for the cell culture,
using special equipment and staff. Moreover, the factors of cost and
stability of the cell culture over time are some questions that arise
and should be answered with a future research.
Au nanoparticles supported onto reduced graphene oxide (r-GO)
were explored by some groups as transducer electrode material. Cur-
rently, graphene and its derivatives (graphene oxide or reduced gra-
phene oxide) are considered among the most promising materials for
the development of biosensors, not only because of their high conduc-
tivity, but also of their very good biocompatibility with the human
body [81,82]. However, graphene sheets own strong π-π and hydrogen
interactions that cause its aggregation [83,84]. Before being applied
into a biosensor, the modification of the structure or the surface, as
well as the functionalization of graphene is necessary. When water-
soluble macrocycles or cyclic oligomers are used as functional groups,
a new material is obtained, owing to the properties of graphene (large
surface area, conductivity, etc.) and the functional groups (very high
molecular recognition and ability) [85].
Very recently Ali et al. [74], exploiting the novel aerosol jet 3D-
printing method [86–88] along with the r-GO properties, fabricated
3D Au pillars, being decorated with r-Go nanoflakes (Fig. 6Ai) and
tested as transducer electrode in a novel SARS-CoV-2 capacitive sen-
sor. The functional carboxylate groups of r-GO structure (–COOH
and –OH) combined with the structural properties of Au, offer more
binding sites for viral antigens, using EDC (1-ethyl-3- (-3-dimethylami-
nopropyl) carbodiimide hydrochloride) and DCC (N’, N’, Dicyclohexyl-
carbodiimide) carbodiimide compounds, as schematically depicted in
Fig. 6Ai. Thus, increase the as-suggested sensor sensitivity, allowing
higher redox current (from the electroactive species). Moreover, the
adjusted r-GO to the 3D Au pillars formed a secondary 3D network,
facilitating bind of a greater number of antigens and therefore showing
higher sensitivity.
The response time of the biosensor suggested by Ali et al. [74] was
only 11.5 sec. In the case of phosphate-buffered saline (PBS), the novel
biosensor was able to detect the SARS-CoV-2 protein at concentrations
close to 1 fg/mL (fg/mL = 10−15 g/mL), while in the case of clinical
transport media, the limit increased at 100 fg/mL. Moreover, the pro-
duced signal is possible to be recorded by a smartphone-based user
interface. The biosensor successfully detected SARS-CoV-2, with a
LOD of 16 pfu/mL in culture media and of 2.42 × 102 copies/mL in
clinical samples. The pfu is the plaque-forming unit used in virology
to describe the number of virus particles able of forming plaques/colo-
nies, while the copies/mL is the measure of the virus amount in a
blood sample. In addition, after eluting the antibody-antigen binding,
the as-suggested platform could be used for ten successive screenings,
presenting accuracy and reproducibility among the measurements.
The technique of electrochemical impedance spectroscopy was
used for the evaluation of the as-fabricated sensor. More specifically,
when the analysis sample does not contain any virus molecule, an elec-
trical double layer (Cdl) between the electrode and the electrolyte (buf-
fer saline solution with ferro/ferricyanide) is created, which is
consisted of an inner and an outer Helmholtz plane (IHP &OHP). How-
ever, when a virus is present in the test sample, by applying a specific
potential the targeted antibodies combine with the antigens already
bound onto the r-GO nanoflakes, increasing the double layer thickness,
Fig. 6. (Ai) Functionalized r-GO sheets with carboxylated groups, using a drop-casting process, enriching the r-GO surface with –COOH and –OH groups. (Aii)
Schematic representation of the electrical double layer (consisted of Helmholtz planes: OHP & IHP), created between the electrode and the electrolyte. (Aiii) After
the targeted antibodies bound with electrode’s antigens, the charge capacitance increases with the increase of the double layer width [74]. (Bi) Schematic
illustration of the Au nanoparticles treatment. (Bii) Differential pulse voltammetry (DPV) measurements of the as prepared electrode: i) in blank solution (black),
ii) in 10−12 M of the target (red), iii) in 10−12 M of 2 different mismatch artificial targets (MT) (blue and purple). (Biii) Linear relationship (current vs logCanalyte),
ranging from 10−17 to 10−12 M [75]. Reproduced with permission.
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binding event is validated by the current produced from the electro-
chemical oxidation and the ferro/ferricyanide reaction [74].
Examining how the target concentration affect the impedance sig-
nal, the authors [74] concluded that when the binding sites were all
occupied the impedance signal was not increased, even if the target12analyte concentration increased. This means that there is an impe-
dance signal saturation. This arises questions like whether such sensors
would extract real quantitative results when the target’s concentration
is higher than the saturation value. In this case, the high concentra-
tions might cause competitive adsorption phenomena between the
antibodies on the surface of the antigens and maybe the diffusion phe-
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above parameters affect the behavior of electrochemical biosensor and
require further research efforts, when the validation of the stability of
such biosensor under various environments is desired.
Zhao et al. [75], exploiting the unique properties of r-GO, designed
a portable electrochemical biosensor for the detection of SARS-CoV-2
RNA. More precisely, they functionalized the r-GO surface with p-sul-
focalix[8]arene (SCX8) onto which they deposited Au@Fe3O4 nano-
particles. Label probes and auxiliary probes were also adopted.
Αs schematically seen in Fig. 6Bi, before the deposition of Au nano-
particles on the modified r-GO, the deposition of toluidine blue (TB) is
preceded. The TB is an electrochemical mediator, being selected
because of its high affinity with the SCX8 functional material of the
r-GO. The inclusion of SCX8 in the r-GO structure enhances its sensing
ability. Among the materials developed to be applied as transducer
electrodes for SARS-CoV-2 electrochemical biosensors (Table 2), the
above-presented exhibited the lowest response time, as well the lowest
detectable concentration limit [75]. More precisely, the as-suggested
sensor is based on nucleic acid following the super sandwich-sensing
type, which is consisted of: i) a capture probe (CP, is captured on
the catalytic surface area, usually an antibody), ii) a target sequence
(usually oligonucleotides or DNA or RNA, when the complementary
sequence binds with the target sequence, then an electric signal is pro-
duced), iii) a label probe (organic dyes, enzymes or redox molecules
play the role of the label, which displays a signal when the DNA hybri-
dization is detected) and iv) an auxiliary probe, hexane-1-thiol (HT)
(to ensure the analyte molecule capture).
The as-fabricated biosensor [75] was tested using laboratory and
clinical samples. Its detection ability was estimated by employing
the technique of differential pulse voltammetry (DPV); once the analy-
sis sample contains the virus (target) a certain current is produced (Fig.
6Bii). As Fig. 6Biii shows, the current is linearly proportional to the
concentration of the analyte (current vs logCanalyte), ranging from
10−17 to 10−12 M (mol/L) and exhibiting a lower limit of detection
(LOD) close to 3 aM (aM= 10−18 mol/L). Moreover, its response time
is <10sec, being one of the fastest SARS sensors proposed. It is also
remarkable that no method was used to amplify the signal detection.
However, in the case of clinical samples analysis, the 200 copies/mL
was the lowest detection limit measured, achieving an accuracy of
100%. Moreover, the ability of the biosensor to be connected directly
to a smartphone, with no need of nucleic acid amplification and
reverse transcription, makes it more accessible as a diagnostic tool.
Thus, some of the as-developed sensors for SARS-CoV-2 detection
are based on Au-working electrodes, as Au material consists a safe
choice [89]. For the preparation of these electrodes four different stra-
tegies were adopted: i) the first one, in which Au nanoparticles are
deposited on different electrode substrate (Ti, Si or other) that offers
better characteristics, ii) the second one, in which the Au nanoparticles
are modified with a second element, e.g. r-GO nanoflakes that increase
the Au-nanoparticles binding capacity and sensitivity, iii) the third
one, in which the Au-modified nanoparticles are deposited on a
nano-support (r-GO) that offers more sites for increasing the sensitivity
of host–guest recognition electrochemical biosensors and iv) the fourth
one, in which the membrane cells are used as mediators for the virus
detection.
Recently, some research groups focused their attention on the
development of pure carbon or graphene-based electrodes for applica-
tion in SARS-CoV-2 electrochemical biosensors, as it is below
discussed.
2.2.2. Carbon and graphene-based SARS-CoV-2 electrochemical biosensors
The application of carbon or graphene-based nanomaterials, espe-
cially in the field of electrochemical biosensors, has become more
intense the last decade [90–94], since it is found that the nano-struc-
turing of the transducer-electrode improves by far all their operation
and efficiency features. For example, Chin et al. [95], modifying the13screen printed electrodes with carbon nanoparticles, they noticed that
the charge transfer kinetics was significantly enhanced, and so the cur-
rent response of the biosensor was also improved by 63%.
Very recently Mahari et al. [96], modified the screen-printed elec-
trodes surface with carbon nanoparticles, fabricating a highly sensitive
SARS-CoV-2 electrochemical platform (denoted as eCovSens). For
comparison reasons they also fabricated a home-made biosensor
equipped with a Au-based fluorine doped tin-oxide (FTO) electrode.
The detection procedure of the as-proposed platform was based on
the conductivity changes, caused by the binding events between the
nCovid-19 monoclonal antibody (nCovid-19Ab) and the nCovid-19
antigen (nCovid-19 Ag) immobilized on the electrode. Using the tech-
nique of differential pulse voltammetry, they found that both biosen-
sors exhibited high sensitivity in the Covid-19Ag concentration
range between 10−15 M - 10−6 M. However, the low detection limit
of eCovSens was calculated at 10 fM (fM = 10−15 M), while the Au-
FTO one was estimated at 120 fM [96]. Taking into consideration
the high sensitivity, the ability to be portable, the quick response time
(10–30 s), as well as the low cost of the eCovSens, one might state that
carbon-based electrochemical biosensors can be strong competitors of
the Au-based ones.
Fabiani et al. [97] also modified the surface of graphite screen-
printed electrodes with carbon magnetic beads, fabricating a SARS-
CoV-2 electrochemical immunoassay. Since the magnetic beads have
been set as biocompatible materials [98], their combination with car-
bon black is another biosensor configuration, exploited increasingly.
The magnetic beads (placed under the working electrode) are operat-
ing as the support of the immunological chain and they are able to: i)
accept higher antibody loading due to the high surface to volume ratio,
ii) be moved to a specific volume of analyte and washed to remove
interfering species, iii) increase the selectivity of the working electrode
towards the bioreceptor and iv) improve its sensitivity [99].
The S and N proteins of the SARS-CoV-2 were used as target ana-
lytes, bonded with the immobilized-antibodies on the carbon surface.
For achieving the optimum bonding between the SARS-CoV-2 protein
and the antibody, the latter was labeled with alkaline phosphate
enzyme (1-naphthyl phosphate enzymatic substrate). The use of car-
bon is enhanced the sensitivity of the screen-printed electrode, while
the use of magnetic beads improved its selectivity.
In Fig. 7A (i & ii), the differential pulse voltammetry results from
the infected saliva sample analysis are displayed. The sensor is more
sensitive, towards S-protein (Fig. 7Ai) detection than to N-protein
(Fig. 7Aii). This difference was attributed to the fact that in SARS-
CoV-2 cell the concentration of S-protein is three-times lower than that
of N-protein [97]. In addition, the LOD was estimated to be 19 ng/mL
(ng = 10−9g/mL) and 8 ng/mL for N and S-protein, respectively
(Table 3). However, the suggested biosensor required a relatively high
analysis time close to 30 min, which should be ameliorated with
further research.
The modification of carbon (or graphene) structure or the altera-
tion of its surface composition strongly improves the properties of car-
bon (or graphene), motivating more and more research groups to
explore them in many versions [98]. Surface functionalization, which
is the most common strategy, can be succeeded either by physical
interactions or chemical conjugations [100,101].
The functionality of a nano-material increases the ratio of electrode
surface area to volume, and consequently the electrochemical reaction
rate [14,95]. The titania nanotubes functionalization with Co (Fig.
7Bi), adopted by Vadlamani et al. [102], was the key element for
ensuring: i) the stability and selectivity of the novel SARS-CoV-2 bio-
sensor and ii) the successful immobilization of SARS-CoV-2 spike pro-
tein molecules. As the authors observed, the functionalization of the
catalyst improved three main characteristics of the sensor: i) its selec-
tivity towards the S-Receptor Binding Domain (SRBD) protein, ii) its
sensitivity, showing a linear response in the concentration range
Fig. 7. Voltammogram of: (Ai) S-protein detection and (Aii) P-protein detection [97]; (Bi) TiO2 nanotubes functionalized by Co (Co-TNTs), as electrode material
for a SARS-CoV-2 biosensor; (Bii) Linear response for concentration range between 14 nM and 1400 nM and a detection response time of ~ 30 sec [102]; (Ci)
Schematic illustration of –NH2 groups of the SARS-CoV-2 proteins or antibodies attached to 1-Pyrenebutyric acid (PBA); (Cii) Current response of real samples
detection of the N-proteins, S1-IgG, S1-IgM and CRP [103]; (Di) FET SARS-CoV-2 biosensor; (Dii) For laboratory sample the lower limit of detection of SARS
protein, was recorded at 1 fg/mL and 100 fg/mL [104]. Reproduced with permission.
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7Bii).
The increment of the sensitivity was attributed to the as-formed Co
(OH)2 bonded with TiO2 on the titania nanotubes (TNTs) surface. Dur-
ing the detection, the OH-functional groups of the protein are electro-
chemically oxidized to O−, which in turn interact with Co2+ ions of
the Co-TNTs. Titania nanotube arrays are already reported as an effec-
tive material for application in electrochemical biosensors [105]. Their14good sensing ability is mainly attributed to their special morphology
that offers high area to volume ratio, more pathways for charge trans-
fer and good adhesion to the substrate [106]. Moreover, their surface
functionalization and the addition of defects, seem to create more oxy-
gen vacancy sites, which act as adsorption sites for the protein or the
enzyme of the viruses cells [107].
Graphene alteration by engraving before functionalization its sur-
face with laser, is suggested as an effective strategy for producing
Table 3
Carbon or graphene-based transducer electrode for the SARS-CoV-2 electrochemical detection.
Material Electrochemical
detection techniques







nCovid-19 Ag/nCovid-19 monoclonal Ab 10 ~ 30
sec






SARS-CoV-2, S, N proteins 30 min Real sample: 19 × 106 pg/L for S, N protein






S-RBD/none 30 sec Artificial target:





SARS-CoV-2 Biomolecules (N-protein, S1-IgM, S1IgG,
and C-reactive protein)/blood and saliva
10 min 1) 0.1 × 1012 pg/L and 0.5 × 109pg/L for N-
protein in artificial and real sample
2) 20 × 1012 pg/L and 0.2 × 1012 pg/L for S1-IgG
in artificial and real sample
3) 20 × 1012 pg/L and 0.6 × 1012 pg/L for S1-IgM
in artificial and real sample
4) 10 × 1012 pg/L and 0.1 × 1012pg/L for C-
reactive protein in artificial and real sample
Graphene-sheets coated/field-
effect transistor [104]
– 1) SARS-CoV-2 virus’ Genome/SARS-CoV-2 spike
protein
– 1) 2.42 × 102 copies/mL (in real samples)
2) 100 pg/L (in artificial targets)
G. Balkourani et al. Journal of Electroanalytical Chemistry 893 (2021) 115289high-sensitive biosensors [108,109]. Applying the laser-engraving
strategy, graphene can be produced from polymer films, avoiding
the chemical routes that require high temperature processing [110],
thus permitting low cost mass production and better properties.
Recently, Torrente-Rodriguez et al. [103] fabricated a wireless, por-
table SARS-CoV-2 electrochemical biosensor, consisted of four laser-
engraved graphene working electrodes on polyamide substrate. For
accepting the analyte molecule, graphene surface was functionalized
and modified, using 1-pyrenebutyric acid (PBA), as the functional
group (linker). The π-electrons and the carboxylic groups of PBA form
hydrophobic or non-covalent interactions (π-stacking) with the aro-
matic rings of graphene (electrostatic bonds). Then, the –NH2 groups
of the SARS-CoV-2 proteins or antibodies are attached to the PBA,
while BSA protein is also introduced, hindering other molecules to
be adsorbed onto the surface (Fig. 7Ci).
Contrary to the common functionalization, in which the functional
groups directly bind the sp2 carbon atom by modifying its edges and by
introducing defects, pyrene can provide a non-covalent functionaliza-
tion, assuring that the graphene structure and consequently its electro-
nic structure will not be disturbed when the required receptor is
attaching on its surface. When disruptions appear, the receptor and
consequently the detection ability of the biosensor will be partially
deactivated [111].
The step-by-step functionalization of graphene was initially evalu-
ated by applying differential pulse voltammetry and electrochemical
impedance, under open circuit conditions. It was observed that after
each modification step the peak current was decreased, while the resis-
tance increased, proving the successful functionalization. The perfor-
mance of the biosensor platform [103] was then evaluated, using the
amperometric technique and by increasing the analyte concentration
and recording the current response. The detected target-analytes were:
i) proteins (N-protein and C-reactive protein), existing in the virus gen-
ome and ii) specific immunoglobulins (S1-IgG and S1-IgM), produced
from the immune response of the infected patient.
The specific lower limit of detection, recorded for each one of the
analytes, is listed in Table 3. More precisely, the as-fabricated biosen-
sor was evaluated using electrochemical impedance spectroscopy (EIS)
and differential pulse voltammetry (DPV). Fig. 7Cii shows the current
response of the biosensor being tested with real samples, containing:
N-proteins, S1-IgG, S1-IgM and C-reactive protein (CRP). Furthermore,
the lower detection limits, in blood and saliva respectively, were as fol-
lows: i) 0.1 g/L and 0.5 mg/L for N-protein, ii) 20 g/L and 0.2 g/L for
S1-IgG, iii) 20 g/L and 0.6 g/L for S1-IgM, and iv) of 10 g/L and 0.1 g/
L for C-reactive protein. Additionally, the as-proposed sensor [103]15showed a quick response and accuracy in a time period of 10 min
(Table 3).
Graphene, as a two-dimensional material, is able to adsorb the ana-
lyte molecule without any pretreatment, however, running the risk to
be easily contaminated [112]. Thus, in order to overcome this chal-
lenge, different strategies for changing graphene’s properties to the
desired ones, including surface modification as well as functionaliza-
tion, have been proposed [113].
Another type of biosensors for the detection of viruses is the field
effect transistors (FET), in which graphene was adopted the last few
years as the active material [113-115]. Recently, a promising electro-
chemical FET SARS-CoV-2 biosensor, applying graphene sheets as sen-
sing material, was fabricated by Seo et al. [104]. The operation
principle of the as-fabricated biosensor is based on the detection of
SARS-CoV-2 spike protein bound on its antibody, which can be immo-
bilized on graphene sheets through a probe linker (1-pyrenebutyric
acid N-hydroxysuccinimide ester, denoted as PBASE) (Fig. 7Di). The
PBASE inclusion in the graphene sheets caused its chemical functiona-
lization, creating π-π bonds between them. The operational parameters
of the suggested biosensor were studied amperometrically over labora-
tory cultured SARS-CoV-2 and over real patient samples. The sensor's
LOD for SARS protein, was recorded at 1 fg/mL and 100 fg/mL for
laboratory and for real samples, respectively (Fig. 7Dii). While the
LOD for the SARS-CoV-2 biosensor was 1.6 × 10 pfu/mL in laboratory
medium and 2.42 × 102 copies/mL in real samples [116].3. Concluding remarks
Looking for the most effective COVID-19 detection ways, electro-
chemical biosensors could be a very promising one for: i) accurate,
ii) low cost, iii) high sensitivity, iv) quick and v) portable detection,
acting as supplementary to the current diagnostic tools for controlling
the COVID disease expansion. In this report we present a detailed
review on the up-to-date developed SARS-CoV-2 electrochemical bio-
sensors, focusing on their classification based on the transducer elec-
trode material.
Currently, two main groups of materials have been thoroughly
explored as transducer electrodes: i) the Au-based and ii) the carbon
or graphene-based ones. Both present faster response time (few sec-
onds) along with higher accuracy than the current detection methods.
They display high sensitivity values, reaching even the aM scale
(=10−18M), while their specificity is also comparable to the current
detection methods and they can be portable and miniaturized.
G. Balkourani et al. Journal of Electroanalytical Chemistry 893 (2021) 115289Comparing the two groups, we concluded that the carbon or gra-
phene-based electrodes can compete the Au-based ones, as they have
similar or even better operational characteristics, also offering the
advantage of lower cost. The use of nanomaterials into electrochemical
biosensors can improve their characteristics by far. However, their
synthesis methods, the combination of the different nanomaterials,
their nanostructure (nanoparticles, nanotubes, sheets, functionalized
or not), their size and the way they are used in electrochemical biosen-
sors (labels, support, or auxiliary elements for signal enhancement)
significantly affect their characteristics.
Therefore, in the current review we recognized that in the case of
the Au-based electrodes, Au was mainly used in the form of nanopar-
ticles onto alternative supports (polymer based or other) or supported
onto reduced graphene oxide, before being deposited onto the basic
platform. The inclusion of the r-GO to the Au nanoparticles signifi-
cantly ameliorates SARS-CoV-2 sensor characteristics as it mainly
expands the detection area, on which the virus binds.
In the case of carbon or graphene-based electrodes, the surface
functionalization constitutes the main strategy followed. Especially
graphene and its derivatives, which are considered the most promising
materials, do not contain chemically reactive functional groups that
could help immobilizing analyte biomolecules. Thus, we observe its
surface or structure alteration by: i) doping graphene with another
(bio)element, or ii) creating structure defects, or iii) being used as they
are to modify screen printed carbon electrodes.
Among the applied detection techniques, electrochemical impe-
dance spectroscopy, amperometry and differential pulse voltammetry
are the most used ones. Meanwhile, by applying the amperometric
technique, there is a concern about the ‘real’ electric current response
of the sensor, when operating in environments with high virus concen-
trations, as diffusion phenomena may prevail. Electrochemical impe-
dance spectroscopy, square wave voltammetry and differential pulse
voltammetry are more sensitive and reliable detection techniques,
especially for the very low concentration values of the target analyte.
However, for acquiring the ‘real’ charge, the optimal operation condi-
tions are set each time (Hz or voltage step, or scan rate, etc) according
to the virus concentration. Therefore, exploiting the potential of nano-
materials over time, by applying emerging synthesis strategies (such as
functionalization) for their development, we are optimistic that the
above challenge concerning the detection techniques will be overcome
and soon the first commercial SARS-CoV-2 electrochemical biosensors
will be emerged.
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